Clinical Trial Update: Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for sorafenib with micro-therapy guided by Primovist-enhanced MRI in patients with inoperable hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Magdeburg | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED